§ PHARMACEUTICALS
USD · PharmaceuticalsRAPP
RAPPORT THERAPEUTICS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
88 increased/new, 49 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 7.2M | 0.0% | +1% |
| TRV GP V, LLC | 7.1M | 55.7% | ±0% |
| ARCH Venture Management, LLC | 3.7M | 17.2% | ±0% |
| Capital International Investors | 3.1M | 0.0% | −9% |
| Cormorant Asset Management, LP | 3.0M | 4.6% | −2% |
| Goldman Sachs | 2.9M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for RAPP as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER69.0% · 91 holders
QUALITY / COMPOUNDER25.6% · 16 holders
DEALER / BANK9.7% · 17 holders
PASSIVE / INDEX7.8% · 8 holders
INCOME / DEFENSIVE1.0% · 10 holders
TACTICAL / MACRO0.7% · 1 holder
ACTIVIST0.4% · 1 holder
SYSTEMATIC / QUANT0.0% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for RAPP in the last 180 days.